[Actualization: radiofrequency sympathetic denervation of the renal arteries for refractory arterial hypertension]
Pichon Riviere A, Augustovski F, Garcia Marti S, Alcaraz A, Glujovsky D, Lopez A, Rey-Ares L, Bardach A, Ciapponi A, Dehese J
Record ID 32014000256
Authors' objectives: To assess the available evidence on the efficacy, safety and coverage related aspect regarding RSDRA use for refractory arterial hypertension.
Authors' recomendations: The evidence found was of moderate methodological quality. The use of RSDRA associated to the underlying medical treatment proved to be useful in reducing BP in RAH patients at short and middle term (up to 24 months). The procedure could be taken into account only in those RAH patients under treatment at the maximum tolerated doses and adequate adherence, who have failed with all previous measures and if carried out by highly-qualified professionals. Potential subgroups that might benefit could be patients with RAH and kidney failure, due to increase in their sympathetic activity. Long-term studies are required to further assess its indications as well as its morbidity and mortality.
Project Status: Completed
Year Published: 2013
URL for published report: https://www.iecs.org.ar/home-ets/?cod_publicacion=1540&origen_publicacion=publicaciones
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Renal Artery
- Sympathetic Nervous System
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.